28 October 2015: Conference Day 1

EFIB 2015 will provide 700+ delegates with over 90 presentations tackling the issues of understanding new business models, accessing combined funding and overcoming hurdles in the development of new value chains from raw materials right through to the consumer.

The full agenda is now confirmed and will be a high level of discussion featuring over 15 CEOs from leading biobased industries, European Commission representatives and end users Jaguar Landrover, Akzo Nobel and more.

Confirmed speakers joining us in Brussels, can also be viewed here >>

PLUS: Don't miss our workshops on 27 October - you can choose from enzyme engineering or mapping the potential of a waste-based bioeconomy

EFIB 2015: Opening Plenary

The business of Industrial Biotechnology – new business models and investments driving the European bioeconomy forward

Official EFIB Opening Plenary

Sponsored by:

  1. Welcoming remarks

    Joanna Dupont Inglis and Nathalie Moll, EuropaBio

    Director, Industrial Biotechnology, at EuropaBio will welcome 700 attendees to the 8th edition of EFIB, taking place in the prestigious SQUARE Brussels Meeting Center, followed by an introduction to the opening plenary session by Chair and EuropaBio Secretary General, Nathalie Moll.

  2. Opening keynote address

    Geneviève Pons | Director of WWF European Policy Office

    Geneviève Pons joins the WWF European Policy Office in Brussels on 1st June 2015, taking up her official role as the new Director on 1st July 2015. She is an honorary Director of the European Commission, capping off a 22 years career at the EC. 

  3. European Policy keynote

    Daniel Calleja Crespo, Director General, European Commission, Directorate–General, DG Environment

    The bioeconomy and industrial biotechnology are closely connected to ensuring more sustainable and environmentally friendly industrial production, based on renewable materials and on greener processes. In his new position, heading up DG Environment Daniel Calleja Crespo will join us at EFIB to provide the policy perspective on the potential of the European bioeconomy.

  4. The role for biobased industries and the bioeconomy within the investment, jobs and growth package

    Antti Peltomaki | DG for Internal Market, Industry, Entrepreneurship and SMEs, Deputy Director General of European Commission

    Mr Antti Peltomäki is Deputy Director-General of the Enterprise and Industry DirectorateGeneral since February 2012. In this function, Mr. Peltomäki is responsible for regulatory policy including internal market and standardisation, sustainable growth and EU 2020 which includes industrial innovation and mobility industries, textiles, chemicals, metals, mechanical, electrical industries, raw materials, tourism and key enabling technologies. His overarching aim is to reinforce general management within the directorate-general and represent its policy interests to Member States, stakeholders and other relevant third parties, all with the goal of increasing Europe's competitiveness. Before that, Mr Peltomäki was Deputy Director-General in the Information Society and Media Directorate General where he was firstly responsible for research cooperation in the context of the seventh research framework (2007-2013) and thereafter for regulatory policy in the telecommunications, media and internet fields. 

  5. New business way of thinking to move the biobased industry forward

    Tjerk De Ruiter | CEO of Corbion

    Before joining Corbion Tjerk de Ruiter was Chief Executive Officer and President of LS9, Inc., an industrial biotechnology company based in San Francisco USA. Mr. De Ruiter spent twelve years at Danisco where he served as the Chief Executive Officer of the Genencor division, a leading industrial biotechnology company, and a member of the Danisco Executive Committee.

    Prior to becoming CEO of the Genencor division, Mr. De Ruiter was Chief Operating Officer Cultures, Specialities and Flavours at Danisco responsible for three of the high growth product areas of Danisco.

  6. European investments and bioproducts for the future

    Ilkka Hämälä, CEO, Metsä Fibre Ltd

    Mr. Hämälä was appointed President and CEO of Oy Metsä-Botnia Ab (Metsä Fibre Oy as of 20 February 2012) on 1 September 2008. He has held several positions in the company since 1988.

    Mr. Hämälä has several positions of trust, of which the most important are the following:

    - Member of the Management Group of Metsä Group

    - Member of the Supervisory Board of Ilmarinen Mutual Pension Insurance Company

    - Deputy Member of the Board of Directors of Pohjolan Voima Oy

    Within the Finnish Forest Industries Federation Mr. Hämälä has the following position of trust:

    - Member of the Board of Directors for 2015

  7. Morning refreshments in the exhibition hall sponsored by Sulzer Chemtech and 1-to-1 partnering begins

Bioeconomy and the circular economy

  1. Introduction from Chair

    Dave Keating, Former Editor, European Voice

  2. Macro-economic benefits of a circular economy and the current barriers that exist towards its development

    Joss Bleriot | Executive Officer Lead, Communications and Policy of Ellen MacArthur Foundation

    Jocelyn Blériot, co-founder and executive officer of the Ellen MacArthur Foundation, has an academic background drawing focus on literature, philosphy and sociology. Having  spent most of his career in the media industry as a journalist and editor, he joined Ellen MacArthur in 2007 and is responsible for effective communication of many of the circular economy ideas. 

  3. Innovative partnerships - Carlsberg Circular Community & the Green Fiber Bottle

    Simon Hoffmeyer Boas | Director, Corporate Communications & CSR of Carlsberg Group

    Simon is currently heading up the Sustainable Packaging Programme in Carlsberg Group which includes the Carlsberg Circular Community, a partnership platform where Carlsberg’s suppliers, customers and other stakeholders co-operate to create resource optimised solutions using the Cradle-to-Cradle® design framework. He is further a key driving force behind the development of the world’s first fully bio based and biodegradable beer bottle, the Green Fiber Bottle.

  4. Circular economy meets bioeconomy panel discussion

    Panellists from Zero Waste Europe, Interface, FrieslandCampina and more

    Views on how the circular economy can feed into the bioeconomy, and what role biobased materials are playing into sustainability goals in end-use markets, and where the barriers are towards moving to a future circular economy capitalizing on the potential of biobased.

    Panellists include:
    Joss Bleriot, Head of Editorial and European Affairs, Ellen MacArthur Foundation
    Joan Marc Simon, Director, Zero Waste Europe
    Taco Kingma, Manager Sustainable Business, FrieslandCampina
    Tomas Haglund, Lead Accenture Sustainability Services, Accenture
    Geanne van Arkel, Head of Sustainable Development, Interface
    Hugo-Maria Schally, Head of Unit, Eco-Innovation & Circular Economy, DG Environment, European Commission - invited
    Simon Boas Hoffmeyer, Director, Corporate Communications & CSR, Carlsberg Group

  5. Lunch will be served for all speakers and delegates in the exhibition hall

Focused topic sessions Day 1

Creating markets for biobased products

Market oriented session addressing tools such as standards for biobased products, feedstock certification, labelling, public procurement

  1. Introduction from Session Chair

    Alberto Santagostino, Associate Principal, McKinsey & Company

  2. Public Procurement for promoting Europe’s Biobased Industry: Making it Happen

    James Cogan | Business and Policy Analyst of PNO Innovation

    James’s job is the development of strategies, projects and financing actions in support of EU policy in the areas of innovation, competitiveness, science, environment, energy, transport and industry. Recently, with PNO, he has worked on a public procurement study with EuropaBio and these results will be presented, in order to help industries understand how to make it happen for biobased.

  3. Opening bio-based markets via standards, labelling and public procurement

    Ortwin Costenoble | Senior Standardization Consultant of NEN Energy Resources

    The advantage of bio-based products is that they are from biological origin, thus allowing lowering the use of fossil sources, and may have an inherent property of naturally or industrially degrading. Plus they may present additional new properties. In order to proof these advantages, a total concept of bio-content and end-of-life determination techniques combined with advices regarding how to present the product result and the implementation of labelling systems should allow European producers to effectively market their products. This total concept is being developed by the European Standardization Organization, CEN, supported by several co-normative research projects. This presentation aims to explain the standardization and research work, to reflect on its recent accopmplishments and to allow the audience a glance into what the future will bring.

  4. Learning from the Italian advanced biofuels mandate

    Piero Cavigliasso | Director of Institutional Relations and Public Funding of BIOCHEMTEX

    Piero is responsible for strategic development and management of corporate and government relationships, and is keenly aware of the workings of the Biofuels Mandate in Italy and how this has impacted industry, information on which he will share in this session.

  5. Learnings from the US Biopreferred Program

    Ron Buckhalt, BioPreferred Program Manager, USDA

  6. Communicating more sustainable business solutions for a green economy

    Dr Conrad von Kameke | Global Head Public Affairs of Novozymes

    As Novozymes` Global Head Public Affairs, Conrad is responsible for driving the company`s work with governments and international organizations around the world. Conrad will share Novozymes' views on communicating the sustainability of business solutions in relation to the creation of markets for biobased products.

  7. Panel discussion

  8. Networking refreshment break

Feedstock session: Ensuring sufficient and competitive supply in Europe

  1. Introduction from Session Chair

    Dr Calliope Panoutsou, Imperial College Centre for Energy Policy & Technology

  2. Introductory standpoints from panelists

    With representatives from LMC International, European Fermentation Group, COPA COGECA and e4tech

    • Dr Sarah Hickingbottom, Business Development Manager - Oleo & Bio Based Chemicals, LMC International
    • Jamie Fortescue, Director General, Starch Europe
    • Marc Vermeulen, Secretary General, European Fermentation Group
    • Lucy Nattras, Managing Consultant and E4tech sector lead on Biofuels and Biochemicals
  3. Panel discussion

    A discussion of the challenges with feedstock availability in Europe, and how to ensure a sufficient and competitive supply of biomass and other biobased feedstocks that are critical to the future development of the bioeconomy

  4. All conference attendees will be invited to join us an evening drinks reception

    Details to be announced

Innovation Track 1

SME innovation showcase

  1. Introduction from Session Chair

  2. Bringing a new value-chain to an industrial reality; key enabling factors and 1.3-PDO industrial deployment case study

    Benjamin Gonzalez | CEO of Metabolic Explorer

    In 2014, METEX signed an historical strategic partnership that will bring its innovative proprietary PDO process (1,3 Propanediol) to an industrial reality. This significant milestone participates to the creation of a new sustainable value-chain and definitely changes the landscape of the bio-industry.

    To successfully pursue the industrialization and commercialization of its other products (1,2 Propanediol and L-Methionine), METEX will build on its proven experience on 1,3-PDO development, implementing a strategy dedicated to meet the requirements and specificities of its industrial partners, which will be explained in this presentation.

  3. Platform chemical 5-HMF – building the bio-based future

    Thomas M. Kläusli | Chief Marketing Officer of AVA BIOCHEM

    A recent technological breakthrough achieved by AVA Biochem in Switzerland has opened up a long-awaited pathway to industrial applications for the bio-based sector.

    Thanks to AVA Biochem’s recently developed proprietary hydrothermal processing technology, it is now possible to industrially produce renewable platform chemical 5-Hydroxymethylfurfural (5-HMF). A versatile chemical, 5-HMF is the basis for 175 downstream chemicals and over 20 performance polymers. Available from a range of carbohydrates such as fructose, glucose, sucrose, cellulose and inulin, bulk scale production of 5-HMF will strongly impact the bio-based industry. 

  4. Synthetic biology: need for a genetic firewall

    Dr Philippe Gabant | Co-founder and CSO of Syngulon

    Syngulon is developing original genetic technologies to improve the efficiency of microorganisms (also called microrefineries) involved in industrial bioproduction. During the recent years development of microbial bio-based products has emerged. These new applications require deep genetic engineering (also called Synthetic Biology) of industrial microbial genomes to achieve high production yield and improve compatibility with the environment due to production in (semi-) open plants.  The goal of Syngulon is to develop a genetic firewall, to limit genetic interference between microrefineries and the environment.  This genetic firewall is designed to solve both the questions of genetic containment and fight microbial contaminations in the fermentation process.  One key element of the genetic firewall is the use of the natural bacteriocins loci. 

  5. Development of synthetic biology tools to more predictably clone, express and select biocatalytic activities for metabolic pathway and bioprocess optimisation

    Dr Ian Fotheringham | Managing Director of Ingenza

    A description of the application of Ingenza’s proprietary synthetic biology tools to enable more predictably engineer biological production systems with reference to commercially relevant examples.  These tools include protein engineering to address poor response during the control of gene expression, the development of synthetic landing pads to optimise the genomic operating environment around delivered genes, the use of genome editing and RNA trafficking systems to control gene expression, the application of transciptomics and metabolomics to enhance cell system performance, the development of synthetic gene expression regulatory elements to better control gene expression and the deployment of our proprietary inABLE combinatorial genetics platform for large scale gene/pathway assembly and optimisation.  

  6. The use of captured CO2 to produce polyurethane polymers

    Simon Waddington | Market Development Manager of Novomer Inc

    Outline of the current state of the art in utilisation of  CO2 as source of carbon for producing polyurethane polymers. Including a discussion of the various applications that are starting to use this technology this includes adhesives, paints, sealants, flexible foams and insulation foam, highlighting the positive potential impact these technologies will have in the future.

  7. Sustainable chemistry solutions for next generation in situ soil remediation, water treatment, healthcare and life science

    Frederic Lakaye, Manager, Biorem Engineering

    Full scale technology validation cleaning up 70 hectares of sediments contaminated by oil and polychlorobiphenyls in Belgium. BioCat is a biobased bimetallic catalyst for complete hydrodehalogenation of carcinogenic compounds such as pcb’s, pesticides, dioxins and chlorinated solvents. The product applied was manufactured using bacterial extracellular polysaccharides where nanoparticles noble metal hot spots, whose diameter is between 0,1 to 5 nm, are caught in a maze of the EPS. This inhibits the coagulation of the bio-precipitated noble metal into a microparticle. The result is the best available technology and a reactive product without loss of activity over time. 

  8. Networking refreshment break

Biomaterial innovations in consumer goods – showcasing IB as a commercial reality

Sponsored by:

  1. Introduction from Session Chair

    Kathryn Sheridan | Founder of Sustainability Consult

    Kathryn Sheridan is a leading biomaterials communications consultant and global advocate for the bioeconomy.  Before setting up Sustainability Consult, she worked as an environment and energy journalist.  Kathryn will share her experience on how to engage with stakeholders and facilitate communications both within the industry and with external audiences.

  2. Developing a methodology to track and report bio based content in complex supply chains

    Alistair Reid | Spend Area Main Buyer - Renewable Raw Materials of Akzo Nobel

    AkzoNobel and Solvay have joined forces with EY (Ernst & Young) to jointly develop a monitoring system that tracks and quantifies the use of renewable raw materials in paints, coatings and other applications.

    Under this new agreement, Solvay, AkzoNobel and EY developed a "chain of custody methodology" to ensure that even in situations where no physical segregation of petro and bio-based materials is practiced, volumes may still be assigned and reported.
     

  3. Biobased and Jaguar Landrover’s environmental innovation programme

    Ian Ellison | Sustainability Manager of Jaguar Landrover

    Detailing why JLR chose bio-based, what role it plays in their Environmental Innovation programme and how they decide these things and future prospects in this space.

    Ian manages sustainability in product development for Jaguar Land Rover, including systematic analysis of all life cycle stages, covering economic, social and environmental impacts.  Ian leads a sustainability team who develop and deploy tools, analysis and innovations towards product sustainability, sustainable value chains, natural capital protection and a circular economy.

  4. Bioserie Bioplastic Baby Products

    Kaya Kaplancali | CEO of Bioserie

    While their diversification into baby products is relatively recent, Bioserie have been developing and marketing durable bioplastic consumer products since 2009. They have accumulated a significant level of expertise regarding marketing and branding of biobased products. They identified several challenges in developing and marketing biobased products such as:

    • Supply chain and manufacturing challenges, especially in regards to cost-effective biopolymers
    • “Greenwashing” or negative effects of excessive use of “green” advertising claims by small and large brands alike
    • Lack of well known standards and certification schemes to guide and educate consumers
    • Mainstream consumers’ lack of awareness or misguided views about what truly is a biobased or sustainable product

    They have developed their own strategies to tackle these challenges, and will share their views during the EFIB 2015 event.

  5. Pharmafilter: provision of single, personal and hygiene, use bioplastics disposables for hospitals

    Peter Kelly | Pharmafilter International Director Healthcare, Waste, Wastewater and BioBased Biodegradable Platform Solutions of Pharmafilter

    Presenting Cellulac and Pharmafilter's partnership agreement to secure a vertically integrated supply chain for the provision of single, personal and hygiene, use bioplastics disposables for hospitals that will have an end-of-life cycle that incorporates energy and heat recovery, cleaning of contaminated water and management of complex waste.

  6. Performance enabled by Nature

    Gesa Behnken | Head of New Technologies, Business Unit Coatings, Adhesives and Specialties, Covestro and Babette Pettersen | Chief Commercial Officer, BioAmber

    Babette Pettersen has served as Chief Commercial Officer since October 2012. From 2011 to October 2012, Ms. Pettersen served as Senior Vice President of Marketing and Sales.

    From 2007 to 2010, Ms. Pettersen was Vice President of New Business Development for Performance Materials at Royal DSM N.V., where her team worked on identifying new business platforms for DSM’s Performance Materials Business.

    Soon to be announced, who from Bayer will be co-presenting.

  7. All conference attendees will be invited to join us an evening drinks reception

    Details to be announced